About APHIOS CORP
Aphios Corporation is a biotechnology company focused on developing therapeutics for cancer, infectious diseases, and CNS disorders using sustainable science and proprietary technology platforms. The company has 85+ patents, $20M in NIH grants, and a $1.6B peak-sales asset.
Drug discoveryPharmaceutical manufacturingNanotechnology drug deliveryPathogen safety technologyCannabinoid-based drug developmentBiotechnology for infectious diseases and CNS disorders
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to APHIOS CORP right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.